I'm confused. Is the CE Mark application for pancreatic cancer submitted or not? In this ann it says,
"..OncoSil Medical plans to file for CE Mark in both pancreatic and liver cancer indications in H2, 2015..."
But the last investor update said of pancreatic indication,
"...CE Mark approval by end Q3 2015.."
Have they filed for pancreatic or not??
Ann: OncoSil HCC Announcement, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $146.9K | 18.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 20491639 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 7540000 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |